Previous studies demonstrated that FAM83H‐AS1 has potent tumor‐promoting activity in colorectal carcinoma, breast cancer, bladder cancer, and NSCLC,17, 18, 19, 37 and the overexpression of FAM83H‐AS1 was also shown to be correlated with poor prognosis in OVCA and gastric cancer patients.38, 39. This evidence concerns the gene SACK1H and non-small cell lung carcinoma.